Fibromyalgia Clinical Trials

Find Fibromyalgia Clinical Trials Near You

Neural Mechanisms of Light Driven Analgesia

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study will be to understand the biological mechanisms that are responsible to light-driven analgesia. Light presented to the retina has been shown to have pain relieving properties in pre-clinical and clinical studies. In this study the investigators will evaluate the functional connectivity between subcortical visual areas and non-image forming brain areas that are involved in pain sensation. The investigators will also evaluate how three colored light stimuli presented to the retina results in changes in whole brain evoked activation patterns in participants with chronic musculoskeletal pain and in healthy controls. The investigators will also assess while brain evoked activation patterns in response to a pressure pain stimulus in the presence of three light stimuli in individuals with chronic musculoskeletal pain and healthy controls.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ Adults ≥18 years of age.

⁃ Individuals who do not have any plans for medication or treatment changes for the next 3 months.

⁃ Participants must be willing and able to undergo an MRI.

⁃ Participants must not be claustrophobic

⁃ Participants must be alert and oriented and able to provide informed consent.

⁃ Individuals must be able to speak and read English.

⁃ To be eligible, participants must have a score of ≥7 on the Widespread pain index (WPI) and ≥5 on the symptom severity scale (SSS), or 4-6 on the WPI and ≥9 on the SSS in the 2016 Fibromyalgia Questionnaire.

⁃ Pain symptoms must have been present for 3 months or longer.

⁃ Pain must be present in 4 out of 5 body regions.

⁃ Individuals enrolled will have an average pain severity ≥4 on the 0-10 NRS over the month prior to enrollment to recruit individuals with moderate to severe chronic MSP.

• 2 additional participants without chronic MSP will be recruited with diagnosed congenital stationary night blindness

Locations
United States
North Carolina
University of North Carolina at Chapel Hill
RECRUITING
Chapel Hill
Contact Information
Primary
Matthew Mauck, MD, PhD
matt_mauck@med.unc.edu
919-966-5136
Time Frame
Start Date: 2026-02-01
Estimated Completion Date: 2030-01-31
Participants
Target number of participants: 60
Treatments
Experimental: Light Sequence 1
The sequence of stimulus presentation for resting state scans will be Static Green for 8 minutes then Equal Energy White for 8 minutes then S-cone modulating stimuli for 8 minutes.
Experimental: Light Sequence 2
The sequence of stimulus presentation for resting state scans will be Equal Energy White for 8 minutes then Static Green for 8 minutes then S-cone modulating stimuli for 8 minutes.
Experimental: Light sequence 3
The sequence of stimulus presentation for resting state scans will be Equal Energy White for 8 minutes then S-cone modulating for 8 minutes then Static Green stimuli for 8 minutes
Experimental: Light Sequence 4
The sequence of stimulus presentation for resting state scans will be Equal Energy White for 8 minutes then S-cone modulating for 8 minutes then Static Green for 8 minutes
Experimental: Light Sequence 5
The sequence of stimulus presentation for resting state scans will be S-cone modulating for 8 minutes then Static Green for 8 minutes then Equal Energy White stimuli for 8 minutes
Experimental: Light Sequence 6
The sequence of stimulus presentation for resting state scans will be Static Green for 8 minutes, S-cone modulating for 8 minutes, then Equal Energy White for 8 minutes
Related Therapeutic Areas
Sponsors
Leads: University of North Carolina, Chapel Hill
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)

This content was sourced from clinicaltrials.gov